Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.76 |
| ▸ | CPA1 | P15085 | 7/20 | 0.66 |
| ▸ | CPA3 | P15088 | 3/20 | 0.66 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.66 |
| ▸ | CPB1 | P15086 | 1/20 | 0.66 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.66 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.59 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.59 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.59 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9068298 | 1.00 | CYP1A2 (0.76) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL9068183 | 1.00 | CYP1A2 (0.76) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL4664822 | 0.87 | CYP1A2 (1.00) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7432418 | 0.85 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL9875948 | 0.85 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL9622038 | 0.85 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL7439697 | 0.85 | CYP1A2 (0.86) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL27291058 | 0.85 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL22115491 | 0.85 | CYP1A2 (0.95) | CYP1A2CPA1CPA3FOLH1CPB1 | |
| SCHEMBL1041958 | 0.84 | CYP1A2 (0.59) | CYP1A2CPA1CPA3FOLH1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2903979-B1 | NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES | INHIBIKASE THERAPEUTICS INC (US) | 2020-08-19 | — | — | EP | claimed |
| JP-7316094-A | — | — | None | — | — | JP | disclosed |
| US-20050143593-A1 | Process for producing 2-aralkylpropionic acid derivative | KANEKA CORPORATION (JP) | 2005-06-30 | — | — | US | disclosed |
| EP-1466895-A1 | PROCESS FOR PRODUCING 2-ARALKYLPROPIONIC ACID DERIVATIVE | KANEKA CORPORATION (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-5587510-A | ASYMMETRICAL HYDROGENATION USING RUTHENIUM-PHOPSHINE COMPLEX AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1996-12-24 | — | — | US | disclosed |
| JP-H07316094-A | (S)-2-ARALKYL-3-CHLOROPROPIONIC ACID AND ITS PRODUCTION | TAKASAGO INTERNATL CORP | 1995-12-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143593-A1 | Process for producing 2-aralkylpropionic acid derivative | AASDHPPT, ADSL, HACL2 | CYP1A2 1178/4885CPA1 1876/4885CPA3 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.